<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00691067</url>
  </required_header>
  <id_info>
    <org_study_id>GW060048</org_study_id>
    <nct_id>NCT00691067</nct_id>
  </id_info>
  <brief_title>A Controlled Trial of Mifepristone in Gulf War Veterans With Chronic Multisymptom Illness</brief_title>
  <official_title>A Randomized, Double-blind Placebo-controlled Crossover Trial of Mifepristone in Gulf War Veterans With Chronic Multisymptom Illness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bronx Veterans Medical Research Foundation, Inc</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>U.S. Army Medical Research and Materiel Command</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Bronx Veterans Medical Research Foundation, Inc</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We propose to conduct placebo-controlled trial of the glucocorticoid receptor antagonist
      mifepristone in Gulf War veterans (GWV) with chronic multisymptom illness (CMI) to examine
      its effects on physical and mental health and cognitive functioning. In addition, we propose
      to examine whether HPA axis biomarkers or their response to mifepristone are useful
      predictors of clinical response.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2008</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in the health components score of the veterans RAND 36-item health survey (VR-36)</measure>
    <time_frame>baseline, every two weeks, endpoint</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>cognitive functioning and measures of depression, fatigue and PTSD</measure>
    <time_frame>baseline and endpoint</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">65</enrollment>
  <condition>Chronic Multisymptom Illness in Gulf War Veterans</condition>
  <arm_group>
    <arm_group_label>Mifepristone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>600mg of Mifepristone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebos</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>mifepristone</intervention_name>
    <description>200 mg po per day x 6 weeks</description>
    <arm_group_label>Mifepristone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>placebo</description>
    <arm_group_label>Placebos</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Veteran of the 1991 Gulf War

          -  Veteran meets criteria for multisymptom illness

        Exclusion Criteria:

          -  Veteran lacks the capacity to provide consent.

          -  Veteran has a major medical or neurological disorder or traumatic brain injury

          -  Veteran has morning plasma cortisol level less than 5 mcg/dl or a history of adrenal
             insufficiency

          -  Veteran is taking oral corticosteroids

          -  Veteran has a lifetime diagnosis of schizophrenia, schizoaffective disorder or bipolar
             disorder

          -  Veteran has been psychiatrically hospitalized or attempted suicide within the previous
             2 years

          -  Veteran has current suicidal ideation

          -  Veteran is pregnant or breastfeeding or plans to become pregnant within the year (male
             or female) not willing to use appropriate forms of contraception during the study and
             for at least 90 days post treatment.

          -  Women veterans with diseases of the uterus by history or a family history of uterine
             cancer

          -  Known allergy to mifepristone
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julia A Golier, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>James J Peters VA Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>James J Peters VA Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10468</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2008</study_first_submitted>
  <study_first_submitted_qc>June 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 5, 2008</study_first_posted>
  <last_update_submitted>January 30, 2017</last_update_submitted>
  <last_update_submitted_qc>January 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bronx Veterans Medical Research Foundation, Inc</investigator_affiliation>
    <investigator_full_name>Julia Golier</investigator_full_name>
    <investigator_title>Clinical Director, Mental Health Patient Care Center</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mifepristone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

